يعرض 1 - 20 نتائج من 479 نتيجة بحث عن '"Zeisel, Mirjam, B."', وقت الاستعلام: 0.94s تنقيح النتائج
  1. 1
    Academic Journal

    المصدر: ISSN: 0168-8278 ; Journal of hepatology, vol. 78, no. 2 (2023) p. 343-355.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/36309131; https://archive-ouverte.unige.ch/unige:166503; unige:166503

  2. 2
    Academic Journal

    المصدر: Roehlen , N , Saviano , A , El Saghire , H , Crouchet , E , Nehme , Z , Del Zompo , F , Jühling , F , Oudot , M A , Durand , S C , Duong , F H T , Cherradi , S , Gonzalez Motos , V , Almeida , N , Ponsolles , C , Heydmann , L , Ostyn , T , Lallement , A , Pessaux , P , Felli , E , Cavalli , A , Sgrignani , J , Thumann , C , Koutsopoulos , O , ....

    وصف الملف: application/pdf

  3. 3
    Academic Journal

    المساهمون: Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), University of Texas Southwestern Medical Center Dallas, Massachusetts General Hospital Boston, Harvard Medical School Boston (HMS), German Cancer Research Center - Deutsches Krebsforschungszentrum Heidelberg (DKFZ), Universität Heidelberg Heidelberg = Heidelberg University, Nouvel Hôpital Civil de Strasbourg, Les Hôpitaux Universitaires de Strasbourg (HUS), University Hospital Basel Basel, Hiroshima University, Icahn School of Medicine at Mount Sinai New York (MSSM), Kumamoto University, Broad Institute Cambridge, Harvard University-Massachusetts Institute of Technology (MIT), Catholic University of Leuven = Katholieke Universiteit Leuven (KU Leuven), Johannes Gutenberg - Universität Mainz = Johannes Gutenberg University (JGU), University Medical Center of the Johannes Gutenberg-University Mainz, Centre d’Infection et d’Immunité de Lille - INSERM U 1019 - UMR 9017 - UMR 8204 (CIIL), Institut Pasteur de Lille, Pasteur Network (Réseau International des Instituts Pasteur)-Pasteur Network (Réseau International des Instituts Pasteur)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Lille-Centre Hospitalier Régional Universitaire CHU Lille (CHRU Lille)-Centre National de la Recherche Scientifique (CNRS), Immunopathologie et chimie thérapeutique (ICT), Institut de biologie moléculaire et cellulaire (IBMC), Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS), Geneva University Hospital (HUG), Massachusetts Institute of Technology (MIT), Harvard University, This work was supported by ARC, Paris and Institut Hospitalo-Universitaire, Strasbourg (TheraHCC1.0 and 2.0 IHUARC IHU201301187 and IHUARC2019 to T.F.B.), the European Union (ERC-AdG-2014-671231-HEPCIR to T.F.B. and Y.H., EU H2020-667273-HEPCAR to T.F.B. and M.H., and INTERREG-IV-Rhin Supérieur-FEDER-Hepato-Regio-Net 2012 to T.F.B. and M.B.Z), ANRS, Paris (2013/108 and ECTZ103701 to T.F.B), NIH (DK099558 to Y. H., and CA233794 to Y.H. and T. F. B, CA140861 to B.C.F., and CA209940, R21CA209940, and R03AI131066 to N.P. and T.F.B.), Cancer Prevention and Research Institute of Texas (RR180016 to Y.H.), US Department of Defense (W81XWH-16-1-0363 to T.F.B. and Y.H.), the Irma T. Hirschl/Monique Weill-Caulier Trust (Y.H.), and the Foundation of the University of Strasbourg (HEPKIN to T. F. B. and Y. H.) and the Institut Universitaire de France (IUF, T.F.B.). M.H. is supported by an ERC CoG grant (HepatoMetaboPath) and EOS grant and by the Deutsche Forschungsgemeinschaft (DFG, German Research Foundation)—Project-ID 272983813—TRR 179, and Project-ID 314905040 SFB TR209. This work has been published under the framework of the LABEX ANR-10-LABX-0028_HEPSYS and Inserm Plan Cancer and benefits from funding from the state managed by the French National Research Agency as part of the Investments for the future program., ANR-10-LABX-0028,HepSys,Functional genomics of viral hepatitis and liver disease(2010), European Project: 671231,H2020,ERC-2014-ADG,HEPCIR(2016), European Project: 667273,H2020,H2020-PHC-2015-two-stage,HEP-CAR(2016)

    المصدر: ISSN: 2041-1723.

    مصطلحات موضوعية: [SDV.CAN]Life Sciences [q-bio]/Cancer

    Relation: info:eu-repo/semantics/altIdentifier/pmid/34535664; info:eu-repo/grantAgreement//671231/EU/Cell circuits as targets and biomarkers for liver disease and cancer prevention/HEPCIR; info:eu-repo/grantAgreement//667273/EU/Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities./HEP-CAR; PUBMED: 34535664; PUBMEDCENTRAL: PMC8448834

  4. 4
    Academic Journal

    المساهمون: Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Génétique et épigénétique des maladies métaboliques, neurosensorielles et du développement (Inserm U781), Université Paris Descartes - Paris 5 (UPD5)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Morphogénèse et antigénicité du VIH, des Virus des Hépatites et Emergents (MAVIVHe), Université de Tours (UT)-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut de Génomique d'Evry (IG), Université Paris-Saclay-Institut de Biologie François JACOB (JACOB), Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Direction de Recherche Fondamentale (CEA) (DRF (CEA)), Commissariat à l'énergie atomique et aux énergies alternatives (CEA)-Commissariat à l'énergie atomique et aux énergies alternatives (CEA), Architecture et Réactivité de l'ARN (ARN), Institut de biologie moléculaire et cellulaire (IBMC), Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)-Centre National de la Recherche Scientifique (CNRS), Institute for Advanced Biosciences / Institut pour l'Avancée des Biosciences (Grenoble) (IAB), Centre Hospitalier Universitaire CHU Grenoble (CHUGA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Etablissement français du sang - Auvergne-Rhône-Alpes (EFS)-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes 2016-2019 (UGA 2016-2019 ), Institut Mondor de Recherche Biomédicale (IMRB), Institut National de la Santé et de la Recherche Médicale (INSERM)-IFR10-Université Paris-Est Créteil Val-de-Marne - Paris 12 (UPEC UP12), Interaction virus-hôte et maladies du foie, ANR-10-LABX-0028,HepSys,Functional genomics of viral hepatitis and liver disease(2010), ANR-10-LABX-0036,NetRNA,Network of regulatory RNAs across kingdoms and dynamical responses to biotic and abiotic stresses.(2010), European Project: 671231,H2020,ERC-2014-ADG,HEPCIR(2016), European Project: 667273,H2020,H2020-PHC-2015-two-stage,HEP-CAR(2016)

    المصدر: ISSN: 0017-5749.

    Relation: info:eu-repo/grantAgreement//671231/EU/Cell circuits as targets and biomarkers for liver disease and cancer prevention/HEPCIR; info:eu-repo/grantAgreement//667273/EU/Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities./HEP-CAR

  5. 5
    Academic Journal

    المساهمون: Italian Institute of Technology = Istituto Italiano di Tecnologia (IIT), Università Campus Bio-Medico di Roma / University Campus Bio-Medico of Rome (UCBM), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Università degli studi di Palermo - University of Palermo, National Cancer Institute Regina Elena Rome, Italy, Università degli Studi di Roma "La Sapienza" = Sapienza University Rome (UNIROMA)

    المصدر: ISSN: 0017-5749.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/32114505; PUBMED: 32114505; PUBMEDCENTRAL: PMC7569396

  6. 6
  7. 7
  8. 8
  9. 9
    Academic Journal

    المساهمون: Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Pôle hépato-digestif Strasbourg, Nouvel Hôpital Civil de Strasbourg, Les Hôpitaux Universitaires de Strasbourg (HUS)-Les Hôpitaux Universitaires de Strasbourg (HUS)-Institut Hospitalo-Universitaire de strasbourg, Division of Surgical Oncology Boston, MA, USA, Harvard Medical School Boston (HMS)-Massachusetts General Hospital Cancer Center Boston, MA, USA, Harold C. Simmons Comprehensive Cancer Center Dallas, TX, États-Unis, University of Texas Southwestern Medical Center Dallas, Department of Gastroenterology and Metabolism Hiroshima, Japan (Applied Life Sciences), Hiroshima University-Institute of Biomedical & Health Sciences Hiroshima, Japan, Department of Gastroenterological and Transplant Surgery Hiroshima, Japan, Hiroshima University-Graduate School of Biomedical and Health Sciences Hiroshima, Japan, Hiroshima University, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Center for Cancer Research Boston, MA, USA, Massachusetts General Hospital Boston, Department of Medicine Boston, MA, USA, Harvard Medical School Boston (HMS), CeMM Research Center for Molecular Medicine Vienna, Austria, Austrian Academy of Sciences (OeAW), Regensburg Centre for Interventional Immunology Regensburg, Germany (RCI), University Medical Center of Regensburg Regensburg, Germany, Department of Laboratory Medicine Vienna, Austria, Medizinische Universität Wien = Medical University of Vienna, Max Planck Institute for Informatics Saarbrücken, Hôpital universitaire Robert Debré Reims (CHU Reims), Department of Biomedicine Basel, University Hospital Basel Basel, Division of Gastroenterology and Hepatology Basel, Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), This work was supported by the ARC (Paris) and the Institut Hospitalo- Universitaire (Strasbourg, TheraHCC IHUARC IHU201301187 to Thomas F. Baumert), the Foundation of the University of Strasbourg and Roche Institute (HEPKIN to Thomas F. Baumert and Yujin Hoshida), the Agence Nationale de Recherches sur le Sida et les Hépatites Virales (2017/1633 to Thomas F. Baumert), the U.S. Department of Defense (W81XWH-16-1-0363 to Yujin Hoshida and Thomas F. Baumert), the Cancéropôle du Grand-Est (AAP Emergence 2017 to Joachim Lupberger), the National Institutes of Health (DK099558 to Yujin Hoshida), and the Research Program on Hepatitis from the Japan Agency for Medical Research and Development, AMED (17fk0210104h0001 to Kazuaki Chayama). This project has received funding from the European Union’s Horizon 2020 research and innovation program under grant agreement 667273 (HEPCAR to Thomas F. Baumert and Joachim Lupberger). This project has received funding from the European Research Council under the European Union’s Horizon 2020 Research and Innovation Program under grant 671231 (HEPCIR to Thomas F. Baumert and Yujin Hoshida). This work has been published under the framework of the LABEX ANR-10-LABX-0028_HEPSYS, and PLAN CANCER 2014–2019 and benefits from a funding from the state managed by the French National Research Agency as part of the Investments for the Future Program, the French National Cancer Institute, and INSERM., ANR-10-IDEX-0002,UNISTRA,Par-delà les frontières, l'Université de Strasbourg(2010), European Project: 667273,H2020,H2020-PHC-2015-two-stage,HEP-CAR(2016), European Project: 671231,H2020,ERC-2014-ADG,HEPCIR(2016)

    المصدر: ISSN: 0016-5085.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/30836093; info:eu-repo/grantAgreement//667273/EU/Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities./HEP-CAR; info:eu-repo/grantAgreement//671231/EU/Cell circuits as targets and biomarkers for liver disease and cancer prevention/HEPCIR; inserm-02312806; https://inserm.hal.science/inserm-02312806; https://inserm.hal.science/inserm-02312806/document; https://inserm.hal.science/inserm-02312806/file/1-s2.0-S0016508519325065-main.pdf; PUBMED: 30836093

  10. 10
    Academic Journal

    المساهمون: Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Harvard-MIT Division of Health Sciences and Technology Cambridge, Massachusetts Institute of Technology (MIT), Evergrande Center for Immunologic Diseases Boston, MA, USA (Ann Romney Center for Neurologic Diseases), Brigham & Women's Hospital, Harvard Medical School, Laboratoire de Biochimie et de Biologie Moléculaire, Centre Hospitalier Universitaire Strasbourg (CHU Strasbourg), Les Hôpitaux Universitaires de Strasbourg (HUS)-Les Hôpitaux Universitaires de Strasbourg (HUS)-Hôpital de Hautepierre Strasbourg, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Department of Infectious Diseases Heidelberg, Germany, Heidelberg University Hospital Heidelberg, Division of Virus-Associated Carcinogenesis Heidelberg, Germany, German Cancer Research Center - Deutsches Krebsforschungszentrum Heidelberg (DKFZ), The Broad Institute Cambridge, MA, USA, Harvard University-Massachusetts Institute of Technology (MIT), Proteomics Platform Berlin, Germany, Max Delbrück Center for Molecular Medicine Berlin (MDC), Helmholtz-Gemeinschaft = Helmholtz Association-Helmholtz-Gemeinschaft = Helmholtz Association-Helmholtz Society Berlin, Germany, Berlin Institute of Health (BIH), Hiroshima University, Liver Research Project Center Hiroshima, Japan, Massachusetts General Hospital Boston, Harold C. Simmons Comprehensive Cancer Center Dallas, TX, États-Unis, University of Texas Southwestern Medical Center Dallas, Cell Circuits Program Cambridge, MA, USA, Broad Institute of MIT and Harvard (BROAD INSTITUTE), Harvard Medical School Boston (HMS)-Massachusetts Institute of Technology (MIT)-Massachusetts General Hospital Boston -Harvard Medical School Boston (HMS)-Massachusetts Institute of Technology (MIT)-Massachusetts General Hospital Boston, Stanford Center for BioMedical Informatics Research (BMIR), Stanford University, Department of Neurology Cambridge, MA, USA (Ann Romney Center for Neurologic Diseases), Harvard Medical School Boston (HMS)-Brigham and Women's Hospital Boston, Department of Neurology Boston, Harvard Medical School Boston (HMS)-Massachusetts General Hospital Boston, L'Institut hospitalo-universitaire de Strasbourg (IHU Strasbourg), Les Hôpitaux Universitaires de Strasbourg (HUS)-Institut National de Recherche en Informatique et en Automatique (Inria)-l'Institut de Recherche contre les Cancers de l'Appareil Digestif (IRCAD)-La Fédération des Crédits Mutuels Centre Est (FCMCE)-L'Association pour la Recherche contre le Cancer (ARC)-La société Karl STORZ, This work was supported by the European Union (ERC-AdG-2014 HEPCIR to Thomas F. Baumert and Yujin Hoshida and EU H2020 HEPCAR 667273 to Thomas F. Baumert and Joachim Lupberger), the Agence nationale de recherche sur le sida et les hépatites virales (ECTZ4236 to Joachim Lupberger and ECTZ4446 to Armando Andres Roca Suarez), the French Cancer Agency (ARC IHU201301187 to Thomas F. Baumert), the US Department of Defense (W81XWH-16-1-0363 to Thomas F. Baumert and Yujin Hoshida), the National Institutes of Health (National Institute of Allergy and Infectious Diseases R03AI131066 to Nathalie Pochet and Thomas F. Baumert, National Cancer Institute 1R21CA209940 to Nathalie Pochet, Thomas F. Baumert, and Olivier Gevaert, National Institute of Allergy and Infectious Diseases 5U19AI123862-02 to Thomas F. Baumert, National Cancer Institute/Informatics Technology for Cancer Research (ITCR) U01 CA214846 to Nathalie Pochet and Olivier Gevaert), the Fondation de l’Université de Strasbourg (HEPKIN) (TBA-DON-0002) and the INSERM Plan Cancer 2019-2023 to Thomas F. Baumert. This work has benefitted from support by the Initiative of Excellence IDEX-Unistra (ANR-10-IDEX-0002-02 to Joachim Lupberger) and has been published under the framework of the LABEX ANR-10-LAB-28 (HEPSYS). INSERM Plan Cancer, IDEX, and LABEX are initiatives from the French program “Investments for the Future.” The work of Ralf Bartenschlager was supported by the Deutsche Forschungsgemeinschaft (TRR179, TP9). Kazuaki Chayama was supported by the Research Program on Hepatitis from the Japanese Agency for Medical Research and Development (AMED) Japan (JP18fk0210020h0002). The work of Romeo Ricci and Gergö Meszaros was supported by a European Research Council (ERC) starting grant (ERC-2011-StG, 281271-STRESS METABOL), by the European Foundation for the Study of Diabetes (EFSD)/Lilly European Diabetes Research Program grant, and by the ANR-10-LABX-0030-INRT grant, a French State fund managed by the ANR under the frame program Investissements d’Avenir ANR-10-IDEX0002-02., ANR-10-LABX-0028,HepSys,Functional genomics of viral hepatitis and liver disease(2010)

    المصدر: ISSN: 0016-5085.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/30978357; PUBMED: 30978357

  11. 11
    Academic Journal
  12. 12
  13. 13
    Academic Journal
  14. 14
    Academic Journal
  15. 15
    Academic Journal

    المساهمون: Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Stanford School of Medicine Stanford, Stanford Medicine, Stanford University-Stanford University, ANR-10-LABX-0028,HepSys,Functional genomics of viral hepatitis and liver disease(2010), European Project: 671231,H2020,ERC-2014-ADG,HEPCIR(2016), European Project: 667273,H2020,H2020-PHC-2015-two-stage,HEP-CAR(2016)

    المصدر: ISSN: 1664-3224.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/29977246; info:eu-repo/grantAgreement//671231/EU/Cell circuits as targets and biomarkers for liver disease and cancer prevention/HEPCIR; info:eu-repo/grantAgreement//667273/EU/Mechanisms underlying hepatocellular carcinoma pathogenesis and impact of co-morbidities./HEP-CAR; hal-02441612; https://hal.science/hal-02441612; https://hal.science/hal-02441612/document; https://hal.science/hal-02441612/file/fimmu-09-01436.pdf; PUBMED: 29977246

  16. 16
    Academic Journal

    المساهمون: Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Pôle hépato-digestif Strasbourg, Nouvel Hôpital Civil de Strasbourg, Les Hôpitaux Universitaires de Strasbourg (HUS)-Les Hôpitaux Universitaires de Strasbourg (HUS)-Institut Hospitalo-Universitaire de strasbourg, Immunité et cancer (U932), Université Paris Descartes - Paris 5 (UPD5)-Institut Curie Paris -Institut National de la Santé et de la Recherche Médicale (INSERM), Université de recherche Paris, sciences et lettres Institut Curie, Paris, Institut Curie Paris, Department of Genetics and Microbiology Prague, Czech Republic (Faculty of Science), Univerzita Karlova Praha, Česká republika = Charles University Prague, Czech Republic (UK), Department of Neurology Cambridge, MA, USA (Ann Romney Center for Neurologic Diseases), Harvard Medical School Boston (HMS)-Brigham and Women's Hospital Boston, Cell Circuits Program Cambridge, MA, USA, Broad Institute of MIT and Harvard (BROAD INSTITUTE), Harvard Medical School Boston (HMS)-Massachusetts Institute of Technology (MIT)-Massachusetts General Hospital Boston -Harvard Medical School Boston (HMS)-Massachusetts Institute of Technology (MIT)-Massachusetts General Hospital Boston, Interaction virus-hôte et maladies du foie, This work was supported by the European Union (ERC-AdG-2014-671231- HEPCIR, EU H2020-667273-HEPCAR, EU-InfectEra HepBccc), the National Institute of Health (NIAID 1R03AI131066-01A1, NCI R21 CA209940 and NIAID U19AI123862), the Agence Nationale de Recherches sur le Sida et les Hepatites Virales (ANRS, 2015/1099), the Fondation ARC pour la Recherche sur le Cancer (TheraHCC IHUARC IHU201301187), GACR 17-15422S, and a PhD fellowship of the Région Alsace, France. The work has been published under the framework of the LABEX ANR-10-LABX-0028_HEPSYS and benefits from funding from the state managed by the French National Research Agency as part of the Investments for the future program. E.R.V. was supported by an ANRS fellowship (ECTZ50121)., ANR-10-IDEX-0002,UNISTRA,Par-delà les frontières, l'Université de Strasbourg(2010)

    المصدر: ISSN: 0270-9139.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/29679386; inserm-01981524; https://inserm.hal.science/inserm-01981524; https://inserm.hal.science/inserm-01981524/document; https://inserm.hal.science/inserm-01981524/file/Verrier_et_al-Hepatology_2018.pdf; PUBMED: 29679386; PUBMEDCENTRAL: PMC6195855

  17. 17
    Academic Journal

    المساهمون: Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Hospices Civils de Lyon (HCL)

    المصدر: Non-coding RNA Investigation ; https://inserm.hal.science/inserm-01910159 ; Non-coding RNA Investigation, 2018, 2, pp.45 - 45. ⟨10.21037/ncri.2018.07.02⟩

    Relation: inserm-01910159; https://inserm.hal.science/inserm-01910159; https://inserm.hal.science/inserm-01910159/document; https://inserm.hal.science/inserm-01910159/file/Zeisel%20et%20al%20Editorial%20Non%20coding%20RNA%20Investigation%202018.pdf

  18. 18
    Academic Journal

    المساهمون: Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Hospices Civils de Lyon (HCL)

    المصدر: ISSN: 1999-4915 ; Viruses ; https://hal.science/hal-04170759 ; Viruses, 2018, 10 (11), pp.591. ⟨10.3390/v10110591⟩.

  19. 19
    Academic Journal

    المساهمون: Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Université de Strasbourg (UNISTRA), Pôle hépato-digestif, Nouvel Hôpital Civil de Strasbourg, Les Hôpitaux Universitaires de Strasbourg (HUS)-Les Hôpitaux Universitaires de Strasbourg (HUS)-Institut Hospitalo-Universitaire de strasbourg, Centre de Recherche en Cancérologie de Lyon (UNICANCER/CRCL), Centre Léon Bérard Lyon -Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)

    المصدر: ISSN: 0767-0974.

  20. 20
    Academic Journal

    المساهمون: Institut de Recherche sur les Maladies Virales et Hépatiques (IVH), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Pôle hépato-digestif Strasbourg, Nouvel Hôpital Civil de Strasbourg, Les Hôpitaux Universitaires de Strasbourg (HUS)-Les Hôpitaux Universitaires de Strasbourg (HUS)-Institut Hospitalo-Universitaire de strasbourg, This study was supported by funding from the European Union (FP7 HEPAMAB GAN 305600, ERC-2014-AdG-HEPCIR, EU H2020 HEPCAR and Interreg IV-Rhin Supérieur-FEDER-Hepato-Regio-Net 2012), the Agence Nationale de Recherche sur le SIDA (ANRS) (2012/318, 2013/108) the Direction Générale de l’Offre de Soins (A12027MS) and the US National Institutes of Health (1U19AI123862-01). This work has been published under the framework of the LABEX ANR-10-LABX-0028_HEPSYS and benefits from funding from the state managed by the French National Research Agency as part of the Investments for the Future programme. CCC is supported by fellowships from the Canadian Institutes of Health Research (201411MFE-338606-245517) and the Canadian Network on Hepatitis C., ANR-10-IDEX-0002,UNISTRA,Par-delà les frontières, l'Université de Strasbourg(2010), European Project: 305600,EC:FP7:HEALTH,FP7-HEALTH-2012-INNOVATION-1,HEPAMAB(2013), European Project: 671231,H2020,ERC-2014-ADG,HEPCIR(2016)

    المصدر: ISSN: 0017-5749.

    Relation: info:eu-repo/semantics/altIdentifier/pmid/28360099; info:eu-repo/grantAgreement/EC/FP7/305600/EU/Human monoclonal antibody therapy to prevent hepatitis C virus reinfection of liver transplants: advancing lead monoclonal antibodies into clinical trial/HEPAMAB; info:eu-repo/grantAgreement//671231/EU/Cell circuits as targets and biomarkers for liver disease and cancer prevention/HEPCIR; inserm-02315671; https://inserm.hal.science/inserm-02315671; https://inserm.hal.science/inserm-02315671/document; https://inserm.hal.science/inserm-02315671/file/736.full.pdf; PUBMED: 28360099; PUBMEDCENTRAL: PMC5868241